Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism.
about
Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.Nanomedicine in GIAntiprotease therapy in cancer: hot or not?Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury.Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor.Urokinase-type plasminogen activator receptor modulates epileptogenesis in mouse model of temporal lobe epilepsy.
P2860
Q30539738-0DA826C2-65B2-45D8-8521-A1F30B53EEEAQ34719056-D5078AF8-851A-47A6-A335-E2BE8C9E80A1Q36407244-D4A994A3-DDA7-41F6-8453-2D2829ACC873Q37687496-112F82CB-EFF5-434E-920B-A0312615EA04Q37895294-A15637AD-7D55-402F-A9BF-D0381930AD4AQ39975026-F2126006-43C0-4D68-B57A-6F75A31E8E8DQ40288670-23E5AD9C-1767-47BD-869D-48AB9672DAF1Q40872425-721FA7B4-CFC5-4D1B-940A-5256E6528084Q42413752-F500BCC9-BEF5-4B25-8C5A-1FA5EB0C2A87Q43123296-31D69DD5-6C29-4B55-902E-1A0A30514F8DQ46930699-8B95AC03-3BFB-41CE-B967-DAD032D8FF16Q48242715-06DEBF42-EC90-46D4-8973-549ABA86B46B
P2860
Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Species-specific urokinase rec ...... an antiangiogenesis mechanism.
@en
type
label
Species-specific urokinase rec ...... an antiangiogenesis mechanism.
@en
prefLabel
Species-specific urokinase rec ...... an antiangiogenesis mechanism.
@en
P2093
P2860
P1476
Species-specific urokinase rec ...... an antiangiogenesis mechanism.
@en
P2093
Ignacio Gonzales-Gomez
Jaume Pons
Jennifer R Stratton
Shaoqiu Zhuo
Steven Rosenberg
Susan Groshen
Vazgen Khankaldyyan
Walter E Laug
Xingyao Bu
P2860
P2888
P304
P356
10.1038/LABINVEST.3700089
P577
2004-06-01T00:00:00Z
P5875
P6179
1005030854